000 01279 a2200373 4500
005 20250516204457.0
264 0 _c20150129
008 201501s 0 0 eng d
022 _a1552-4604
024 7 _a10.1002/jcph.299
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNafziger, Anne N
245 0 0 _aSeasonal influenza vaccination and technologies.
_h[electronic resource]
260 _bJournal of clinical pharmacology
_cJul 2014
300 _a719-31 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntigenic Variation
650 0 4 _aAntigens, Viral
_xchemistry
650 0 4 _aHealth Priorities
650 0 4 _aHumans
650 0 4 _aInfluenza A virus
_ximmunology
650 0 4 _aInfluenza Vaccines
_xbiosynthesis
650 0 4 _aInfluenza, Human
_xepidemiology
650 0 4 _aBetainfluenzavirus
_ximmunology
650 0 4 _aMass Vaccination
650 0 4 _aPandemics
_xprevention & control
650 0 4 _aSeasons
650 0 4 _aTechnology, Pharmaceutical
_xtrends
650 0 4 _aVaccines, Synthetic
_xchemistry
700 1 _aPratt, David S
773 0 _tJournal of clinical pharmacology
_gvol. 54
_gno. 7
_gp. 719-31
856 4 0 _uhttps://doi.org/10.1002/jcph.299
_zAvailable from publisher's website
999 _c23698545
_d23698545